Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COLBiP: Evaluation of BPR001-615 in Primary Cells and Circulating BiP in Colorectal Adenocarcinomas
NCT07813884Recruiting
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Oct 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
Open-label, single-arm trial of BPR001 in colorectal adenocarcinoma, sponsored by Centre Hospitalier Universitaire de Nice. Primary endpoint: Ex vivo viability of primary colorectal cancer cells after BPR001-615 exposure at Day 5. Started Oct 2026; status: recruiting.
02
Drugs
BPR001
03
Conditions
colorectal adenocarcinoma
Beyond the preview
Go deeper on NCT07813884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07813884.